mikamycin B
| Title | Journal |
|---|---|
| Characterization of MLS(b) resistance among Staphylococcus aureus and Staphylococcus epidermidis isolates carrying different SCCmec types. | Microbiology and immunology 20120901 |
| Distribution, characterization and genetic bases of erythromycin resistance in staphylococci and enterococci originating from livestock. | Zoonoses and public health 20120501 |
| Comparison of BD Phoenix and bioMérieux Vitek 2 automated systems for the detection of macrolide-lincosamide-streptogramin B resistance among clinical isolates of Staphylococcus. | Diagnostic microbiology and infectious disease 20120301 |
| In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates. | International journal of antimicrobial agents 20111001 |
| PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates. | The Journal of antimicrobial chemotherapy 20110901 |
| A study on erm(B)-mediated MLS resistance in Streptococcus pyogenes clinical isolates. | Diagnostic microbiology and infectious disease 20110701 |
| Phenotypic and genotypic study of macrolide, lincosamide and streptogramin B (MLSB) resistance in clinical isolates of Staphylococcus aureus in Tehran, Iran. | Medical science monitor : international medical journal of experimental and clinical research 20110101 |
| Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. | The Journal of antimicrobial chemotherapy 20101101 |
| Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20100901 |
| Macrolide, lincosamide, and streptogramin B-constitutive-type resistance in Corynebacterium pseudodiphtheriticum isolated from upper respiratory tract specimens. | Microbial drug resistance (Larchmont, N.Y.) 20100601 |
| Molecular ecology of macrolide-lincosamide-streptogramin B methylases in waste lagoons and subsurface waters associated with swine production. | Microbial ecology 20100401 |
| [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci]. | Mikrobiyoloji bulteni 20100401 |
| NXL-103, a combination of flopristin and linopristin, for the potential treatment of bacterial infections including community-acquired pneumonia and MRSA. | Current opinion in investigational drugs (London, England : 2000) 20100201 |
| Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany. | Journal of medical microbiology 20090201 |
| Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A). | The Journal of antimicrobial chemotherapy 20090101 |
| Technical note: Occurrence in fecal microbiota of genes conferring resistance to both macrolide-lincosamide-streptogramin B and tetracyclines concomitant with feeding of beef cattle with tylosin. | Journal of animal science 20080901 |
| Macrolide-lincosamide-streptogramin B resistance phenotypes in clinical staphylococcal isolates. | International journal of antimicrobial agents 20080401 |
| Foggy D-shaped zone of inhibition in Staphylococcus aureus owing to a dual character of both inducible and constitutive resistance to macrolide-lincosamide-streptogramin B. | The Journal of antimicrobial chemotherapy 20080301 |
| Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20080101 |
| Macrolide-lincosamide-streptogramin B resistant phenotypes and genotypes for methicillin-resistant Staphylococcus aureus in Turkey, from 2003 to 2006. | Polish journal of microbiology 20080101 |
| Transposon characterization of vancomycin-resistant Enterococcus faecium (VREF) and dissemination of resistance associated with transferable plasmids. | The Journal of antimicrobial chemotherapy 20070801 |
| Structural insights into the non-additivity effects in the sequence-to-reactivity algorithm for serine peptidases and their inhibitors. | Journal of molecular biology 20070323 |
| Detection and prevalence of inducible clindamycin resistance in staphylococci. | Journal of medical microbiology 20070301 |
| Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20070301 |
| [The correlation between phenotypes and genotypes of macrolides, lincosamides and streptogramins B resistance in Staphylococcus aureus]. | Medycyna doswiadczalna i mikrobiologia 20070101 |
| In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes. | Folia microbiologica 20070101 |
| Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance. | Journal of medical microbiology 20060201 |
| Macrolide, lincosamide and streptogramin B resistance in a dominant clone of Australian community methicillin-resistant Staphylococcus aureus. | The Journal of antimicrobial chemotherapy 20051101 |
| Chemoenzymatic approach to enantiopure streptogramin B variants: characterization of stereoselective pristinamycin I cyclase from Streptomyces pristinaespiralis. | Journal of the American Chemical Society 20050706 |
| Presence of macrolide-lincosamide-streptogramin B and tetracycline antimicrobials in swine waste treatment processes and amended soil. | Water environment research : a research publication of the Water Environment Federation 20050101 |
| Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes. | International journal of antimicrobial agents 20040601 |
| Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040515 |
| The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. | Journal of molecular biology 20030725 |
| Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. | The Journal of antimicrobial chemotherapy 20030301 |
| [Macrolide resistance phenotypes and genotypes in group G streptococci]. | Mikrobiyoloji bulteni 20030101 |
| Purification and biochemical characterization of the ErmSF macrolide-lincosamide-streptogramin B resistance factor protein expressed as a hexahistidine-tagged protein in Escherichia coli. | Protein expression and purification 20020601 |
| Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities. | The Journal of antimicrobial chemotherapy 20020101 |
| Analysis of macrolide-lincosamide-streptogramin B (MLS(B)) resistance determinant in strains of Clostridium difficile. | Microbial drug resistance (Larchmont, N.Y.) 20020101 |
| Streptogramin resistance among Enterococcus faecium isolated from production animals in Denmark in 1997. | Microbial drug resistance (Larchmont, N.Y.) 20020101 |
| Unusual inducible cross resistance to macrolides, lincosamides, and streptogramins B by methylase production in clinical isolates of Staphylococcus aureus. | Microbial drug resistance (Larchmont, N.Y.) 20010101 |